Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Binding study of desethyloxybutynin using high-performance frontal analysis method.

Akimasa Shibukaw1, Yuki Yoshikawa, Tomoko Kimura

  • 1Graduate School of Pharmaceutical Sciences, Kyoto University, Japan. akimasas@pharm.kyoto-u.ac.jp

Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|April 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel fenoterol derivatives as suppressors of ERK1/2 phosphorylation in melanoma.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

Correlations between clot waveform analysis parameters and fibrinogen concentrations in cases with and without prolonged activated partial thromboplastin time or prothrombin time.

Clinica chimica acta; international journal of clinical chemistry·2026
Same author

Clinical Features and Prognostic Significance of Pulmonary Metastases in Metastatic Hormone-sensitive Prostate Cancer.

Anticancer research·2026
Same author

Author's reply to 'Bayesian interpretation of febrile neutropenia risk and primary G-CSF prophylaxis during darolutamide triplet therapy'.

Japanese journal of clinical oncology·2026
Same author

Hypoxia-Induced MicroRNAs Confer Survival Advantage in Bladder Cancer by Fine-Tuning Oncogenic Pathways.

Oncology·2026
Same author

A Two-Factor Bedside Prognostic Score Integrating Eastern Cooperative Oncology Group (ECOG) Performance Status and Aggressive Metastatic Burden in Metastatic Hormone-Sensitive Prostate Cancer.

The Prostate·2026
Same journal

Discovery of the efficacious component group of Bu Fei formula and its mechanism of ameliorating chronic obstructive pulmonary disease by inhibiting the IL-33 pathway.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026
Same journal

Integrated in silico transdermal prediction, serum pharmacochemistry, and experimental validation reveal the active constituents and therapeutic mechanism of Aifu Nuangong plaster against primary dysmenorrhea.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026
Same journal

Development and application of a liquid chromatography-tandem mass spectrometry method for the analysis of Areca nut alkaloids in rat plasma for a toxicokinetic study.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026
Same journal

Characterization of lipophilic oil fraction from Primula vulgaris: Chemical profile, antioxidant capacity, and DNA damage assessment.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026
Same journal

EGCG alleviates sepsis-induced myocardial injury by regulating macrophage polarization via the TLR4/MyD88/NF-κB pathway.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026
Same journal

Hydrogen-bonded organic frameworks-immobilized thrombin: Ligand fishing of thrombin inhibitors from Chishao and Chishao-Chuanxiong herbal pair.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026
See all related articles

N-desethyloxybytynin (DEOXY), an oxybutynin metabolite, exhibits strong, enantioselective plasma protein binding, primarily to alpha1-acid glycoprotein (AGP). This binding differs significantly between its (R) and (S) enantiomers, impacting drug disposition.

Area of Science:

  • Pharmacokinetics and Drug Metabolism
  • Biochemistry
  • Analytical Chemistry

Background:

  • Oxybutynin (OXY) is metabolized to N-desethyloxybytynin (DEOXY), a pharmacologically active compound.
  • Understanding the plasma protein binding of DEOXY is crucial for predicting its pharmacokinetic profile and therapeutic efficacy.

Purpose of the Study:

  • To quantitatively and enantioselectively investigate the plasma protein binding of DEOXY.
  • To determine the roles of human serum albumin (HSA) and alpha1-acid glycoprotein (AGP) in DEOXY binding.
  • To compare the binding characteristics of DEOXY enantiomers with those of OXY enantiomers.

Main Methods:

  • High-performance frontal analysis (HPFA) coupled with an on-line HPLC system.
  • Determination of unbound DEOXY enantiomer concentrations in human plasma, HSA, and AGP solutions.

Related Experiment Videos

  • Quantitative analysis of binding affinities (nK) to plasma proteins.

    • Main Results:

    • DEOXY exhibits strong and enantioselective binding in human plasma, with significantly lower unbound fractions for (R)-DEOXY (1.19%) compared to (S)-DEOXY (2.33%) at 5 microM.
    • Alpha1-acid glycoprotein (AGP) is the primary binding protein for DEOXY, showing high binding affinities (nK): 2.97 x 10^7 M^-1 for (R)-DEOXY and 1.31 x 10^7 M^-1 for (S)-DEOXY.
    • Binding affinity to HSA is considerably lower for both DEOXY enantiomers (approx. 8 x 10^3 M^-1) compared to AGP.
    • (R)-DEOXY shows enhanced binding affinity to AGP compared to (R)-OXY, while (S)-DEOXY binding is slightly weaker than (S)-OXY.
    • Competitive binding studies confirm that DEOXY and OXY enantiomers bind to the same site on AGP.

    Conclusions:

    • AGP plays a dominant role in the strong and enantioselective plasma protein binding of DEOXY.
    • The observed differences in binding affinity between DEOXY enantiomers and OXY enantiomers are attributed to hydrophobicity and steric hindrance effects.
    • These enantioselective binding characteristics are critical for understanding the pharmacokinetics and potential therapeutic differences between DEOXY enantiomers.